1. Home
  2. FOXX vs CODX Comparison

FOXX vs CODX Comparison

Compare FOXX & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$5.10

Market Cap

16.9M

Sector

N/A

ML Signal

HOLD

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$0.26

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
CODX
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
15.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
FOXX
CODX
Price
$5.10
$0.26
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.25
AVG Volume (30 Days)
3.0M
1.7M
Earning Date
11-18-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$63,030,415.00
$507,892.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.89
P/E Ratio
N/A
N/A
Revenue Growth
139.29
N/A
52 Week Low
$1.71
$0.23
52 Week High
$11.00
$1.55

Technical Indicators

Market Signals
Indicator
FOXX
CODX
Relative Strength Index (RSI) 51.79 38.84
Support Level $3.67 $0.24
Resistance Level $5.38 $0.30
Average True Range (ATR) 1.01 0.03
MACD -0.04 -0.01
Stochastic Oscillator 33.43 12.97

Price Performance

Historical Comparison
FOXX
CODX

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: